This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Last revision Both sides next revision | ||
documentation:oncology:meeting_notes_2019_aug-29 [2019/08/30 11:41] mgurley |
documentation:oncology:meeting_notes_2019_aug-29 [2019/08/30 13:49] mgurley |
||
---|---|---|---|
Line 4: | Line 4: | ||
+ | * Robert Miller asked about how code that prepares data for the common ETL input format should deal with ambiguous ICDO site/histology combination in multiple NAACCR schemas. | ||
+ | * It was decided that pre-reprocessing code should not consider the ambiguity and rely ETL code to skip ambigious ICDO site/histology combinations. SQL for identifying NAACCR ambiguities is here: https://github.com/OHDSI/OncologyWG/blob/master/documentation/debug_naaccr_ambiguites.sql | ||
* It was agreed that 'Create ICDO concept for 'Unknown Histology' and precoordinate with all ICDO sites.' is not on the critical path for the symposium. | * It was agreed that 'Create ICDO concept for 'Unknown Histology' and precoordinate with all ICDO sites.' is not on the critical path for the symposium. | ||
* https://github.com/OHDSI/OncologyWG/issues/67 | * https://github.com/OHDSI/OncologyWG/issues/67 |